A low-cost antidepressant may offer new hope for people struggling with long COVID fatigue. In a randomized clinical trial involving 399 adults, fluvoxamine significantly reduced fatigue and improved quality of life compared with a placebo, making it one of the first medications to show meaningful benefits for this disabling condition.
🩺 Daily Picks by Our Team
Brought to you by Healthwise Feed’s “Daily Picks” team. Curated from credible health sources.
👉 Follow us @healthwisefeed1 for more wellness tips and updates.
Brought to you by Healthwise Feed’s “Daily Picks” team. Curated from credible health sources.
👉 Follow us @healthwisefeed1 for more wellness tips and updates.
🔗 Read the full article on the original source
💬 Enjoyed this article? Share it with others: